Breathe Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Ghaziabad, Uttar Pradesh, India, established in 2016.
2016 Ghaziabad, Uttar Pradesh, India Struck Off
Last Updated:
Access Report
About Breathe Pharmaceuticals Private Limited

Breathe Pharmaceuticals Private Limited, a struck off private limited company, was established on 01 January 2016 in Ghaziabad, Uttar Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233UP2016PTC075450. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Dheeraj Taneja (Director), Naveen Kumar Bimal (Director). It is based at H.No -126, Viveka Nand Nagar, Ghaziabad, Uttar Pradesh, 201002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233UP2016PTC075450

  • Registration Number

    075450

  • Incorporation Date

    01 January 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 2 Months
Company report

Breathe Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Breathe Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Breathe Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dheeraj Taneja Director 01 Jan 2016 Current
Naveen Kumar Bimal Director 01 Jan 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Breathe Pharmaceuticals.

Enhance accessibility to Breathe Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Breathe Pharmaceuticals revenue growth over time
Breathe Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Breathe Pharmaceuticals?

Unlock access to Breathe Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Breathe Pharmaceuticals?

Unlock and access historical data on people associated with Breathe Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Breathe Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Breathe Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Breathe Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Dheeraj Taneja was appointed as a Director was appointed as a Director on 01 Jan 2016 & has been associated with this company since 10 years 2 months . was documented.

  • Director Appointment

    Progress on Naveen Kumar Bimal was appointed as a Director was appointed as a Director on 01 Jan 2016 & has been associated with this company since 10 years 2 months . was documented.

  • Company Incorporation

    The activity Breathe Pharmaceuticals Private Limited was registered on 01 Jan 2016 with Roc Kanpur & aged 10 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Breathe Pharmaceuticals Private Limited?

The CIN of Breathe Pharmaceuticals Private Limited is U24233UP2016PTC075450.

Where is Breathe Pharmaceuticals Private Limited headquartered?

Breathe Pharmaceuticals Private Limited is headquartered at H.No -126, Viveka Nand Nagar, Ghaziabad, Uttar Pradesh, 201002.

When was Breathe Pharmaceuticals Private Limited incorporated?

Breathe Pharmaceuticals Private Limited was incorporated on 01 January 2016.

Who are the current directors of Breathe Pharmaceuticals Private Limited?

The current directors of Breathe Pharmaceuticals Private Limited are

What is the primary industry of Breathe Pharmaceuticals Private Limited?

The primary industry of Breathe Pharmaceuticals Private Limited is Chemicals.

Is Breathe Pharmaceuticals Private Limited a listed company?

Breathe Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Breathe Pharmaceuticals Private Limited?

The authorized capital of Breathe Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Breathe Pharmaceuticals Private Limited?

The compliance status of Breathe Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available